Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
MacroGenics, Inc.
4107
MacroGenics, Inc.
Health Care
Technology
Biotechnology
MG has the capabilities to discover, develop and deliver to patients novel biologics for the treatment of autoimmune disorders, cancer and infectious diseases.
Suggest edits
Founded
2000
Raised
$45M
Follow us
Companies in the same industry
Pfizer Belgium
Veracyte, Inc.
ConforMIS
Sanovas
Ascension Orthopedics
doublehelix design
Provia Laboratories
Indie Bio SF
Amplyx Pharmaceuticals, Inc
Palatin Technologies
Alexa global traffic share
Twitter followers
Overview
Funding
1
Acquisitions
1
Add info
Latest funding
$45,000,000
Venture capital (Series C) - 2006
Caisse de Depot et Placement du Quebec
InterWest Partners
Alta Partners
+8
Team Size
50+
Employees
I work here
Location
United States
Headquarters
Explore United States
the home of AI info
Comparing of MacroGenics Inc. (MGNX) and Minerva Neurosciences Inc. (NASDAQ:NERV)
MedCity News
FDA places hold on MacroGenics' bispecific antibody trials over liver toxicity concerns
The Motley Fool
Why Charter Communications, MacroGenics, and TD Ameritrade Jumped Today
Stock markets
